Klaus Stöhr

"Klaus Stöhr is Vice President and Global Head of the Influenza Strategy Liaison for Novartis Vaccines in Boston, USA, where he leads and coordinates cross-functional pandemic and prepandemic influenza vaccine activities, as well as driving influenza based interactions with national and international authorities. In 1991, he joined the World Health Organization. Until 2000, he worked in various teams in the Communicable Diseases Department, led the WHO efforts on global rabies and salmonellosis surveillance, and coordinated the WHO global activities on antimicrobials in the food chain. In 2001, he became coordinator of the WHO Global Influenza Program. In 2003, he led the WHO efforts on SARS virus discovery and epidemiological research. In 2006, he was made Special Advisor on Influenza Pandemic Vaccine Development for the WHO Initiative for Vaccine Research. Dr Stöhr is a well respected, internationally-recognized expert; since 1992 he has been invited to give over 165 scientific presentations, been co-author on more than 55 publications, and contributed with chapters to numerous books. Dr Stöhr is an honorary Professor at the Freie University, Berlin, has won a number of scientific awards, and was included in the 2005 Scientific American 50 list of research and policy leaders."

• Influenza Programm 2000-6; before various positions in Communicable Disease and Epidemic Response, World Health Organization - 1992 – Jan 2007 - 15 years [1] [2]
• 2003 - European Scientific Working Group on Influenza (Dr. Klaus Stöhr, Project Leader Influenza, World Health Organisation Geneva, has agreed to become an ESWI adviser. He is replacing Dr. Daniel Lavanchy. [3]